SCHEMBL14848764

SCHEMBL14848764

CC(C)(C)OC(=O)N1CC[C@@H](Oc2c(N)cc(C(F)(F)F)cc2[N+](=O)[O-])C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.44
TDP1 Q9NUW8 1/20 0.44
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
POLB P06746 1/20 0.42
STS P08842 1/20 0.42
ALDH1A1 P00352 2/20 0.40
PIK3CD O00329 4/20 0.40
TACR1 P25103 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
PIK3CA P42336 3/20 0.40
USP30 Q70CQ3 1/20 0.39
GPR119 Q8TDV5 3/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
PIK3CB P42338 2/20 0.38
PIK3CG P48736 2/20 0.38
HDAC1 Q13547 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2336142 0.93 MAPT (0.47) MAPTTDP1CYP2C9CYP2C19POLB
SCHEMBL2335175 0.93 MAPT (0.47) MAPTTDP1CYP2C9CYP2C19POLB
SCHEMBL2339872 0.89 STS (0.51) STSPIK3CDTACR1PIK3CAUSP30
SCHEMBL2339564 0.89 STS (0.51) STSPIK3CDTACR1PIK3CAUSP30
SCHEMBL18615601 0.83 MAPT (0.48) MAPTTDP1CYP2C9CYP2C19POLB
SCHEMBL18615671 0.83 MAPT (0.48) MAPTTDP1CYP2C9CYP2C19POLB
SCHEMBL18615597 0.83 MAPT (0.48) MAPTTDP1CYP2C9CYP2C19POLB
SCHEMBL22694519 0.83 STS (0.43) STSPIK3CDTACR1PIK3CAUSP30
SCHEMBL29116484 0.80 USP30 (0.45) MAPTTDP1STSALDH1A1PIK3CD
SCHEMBL31233745 0.80 USP30 (0.45) MAPTTDP1STSALDH1A1PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8975262-B2 Synthetic mimetics of host defense and uses thereof CELLCEUTIX CORPORATION (US) 2015-03-10 US disclosed
US-20130090345-A1 Synthetic Mimetics Of Host Defense And Uses Thereof POLYMEDIX, INC. (US) 2013-04-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130090345-A1 Synthetic Mimetics Of Host Defense And Uses Thereof TLR3, MYD88, TLR5 MAPT 4705/4885TDP1 4134/4885CYP2C9 4158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.